Vera Therapeutics announced positive final results from their pivotal Phase III trial showing significant efficacy in kidney function improvement. About 10 weeks into their first commercial launch, the company has received over 350 patient prescriptions, indicating strong early demand. They plan to present these data at the upcoming ASN kidney conference and aim for full regulatory approval by mid-2027 through a supplemental Biologics License Application (sBLA) submission in Q4 2026. This marks a major milestone for Vera and patients awaiting new kidney treatment options.
Vera Therapeutics' recent pivotal Phase III trial results and early commercial launch are notable alongside the current health sector market snapshot on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 16, 2026 03:25 WIB: out of 91 priced US health-sector stocks, 55 rose and 36 fell. Key movers include TXG (10X Genomics Inc) at USD 74.50 with a +6.26% change, ADMA (ADMA Biologics Inc) at USD 8.58 with a -6.13% change, and AMWL (American Well Corp) at USD 13.76 with a +5.85% change.
Remittix is set to add 41 new fiat currencies to its PayFi ecosystem, enhancing crypto-to-bank and bank-to-crypto transactions globally ahead of its November 24 RTX launch. This expansion aims to support more international markets and users, includin...
First Pacific Bancorp announced solid third quarter 2026 results, with total assets reaching $532 million, up $42 million from year-end 2025. Deposits increased to $449 million, and loans grew to $362 million, reflecting steady balance sheet expansio...
ICEYE and Nokia have signed a Letter of Intent with Ukraine's Ministry of Defence to collaborate on building sovereign satellite communication capabilities. This partnership aims to enhance Ukraine's defense by providing secure, high-performance sate...
Dayton T. Brown, Inc. inaugurated its new 104,000-square-foot Test & Qualification Center in Huntsville, Alabama, enhancing its capacity to support aerospace, defense, and propulsion programs. The facility's strategic location near Huntsville's aeros...
A new study by The Grossman Group reveals that while 60% of chief communications officers (CCOs) have influence at the leadership level, their communications functions lack the necessary systems, skills, and AI capabilities to fully meet their mandat...
